Therefore, the level of inflammatory factors (such as a high level of IL-1β) in liver failure patients can affect the efficacy of stem cells, but improving the inflammatory environment in liver failure patients prior to the application of stem cell therapy may improve the efficacy of stem cells. The gene discussed is IL1B; the disease is liver failure.